Literature DB >> 15464032

Striatal dopamine D2 receptors in modulation of pain in humans: a review.

Nora Hagelberg1, Satu K Jääskeläinen, Ilkka K Martikainen, Heikki Mansikka, Heli Forssell, Harry Scheinin, Jarmo Hietala, Antti Pertovaara.   

Abstract

We review evidence indicating that the striatum and striatal dopamine D2 receptors are involved in the regulation of pain in humans. Painful stimulation produces an increase in regional cerebral blood flow in the human striatum. Pain is a common symptom in patients with nigrostriatal dopaminergic hypofunction. Positron emission tomography findings show that a low dopamine D2 receptor availability in the striatum of healthy subjects (indicating either a low density of dopamine D2 receptors or a high synaptic concentration of dopamine) is associated with a high cold pain threshold and a low capacity to recruit central pain inhibition by conditioning stimulation. Patients with chronic orofacial pain have higher dopamine D2 receptor availability than their age-matched controls. We propose that the striatal dopamine D2 receptor may be an important target for the diagnosis and treatment of chronic pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464032     DOI: 10.1016/j.ejphar.2004.07.024

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  53 in total

1.  Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours.

Authors:  P N Margariti; L G Astrakas; S G Tsouli; G M Hadjigeorgiou; S Konitsiotis; M I Argyropoulou
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 2.  The striatum and pain modulation.

Authors:  Ana C Barceló; Bárbara Filippini; Jorge H Pazo
Journal:  Cell Mol Neurobiol       Date:  2011-07-26       Impact factor: 5.046

3.  The contribution of the putamen to sensory aspects of pain: insights from structural connectivity and brain lesions.

Authors:  Christopher J Starr; Lumy Sawaki; George F Wittenberg; Jonathan H Burdette; Yoshitetsu Oshiro; Alexandre S Quevedo; John G McHaffie; Robert C Coghill
Journal:  Brain       Date:  2011-05-26       Impact factor: 13.501

4.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

5.  Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals.

Authors:  Yen-Yu I Shih; Yun-Chen Chiang; Bai-Chuang Shyu; Fu-Shan Jaw; Timothy Q Duong; Chen Chang
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

Review 6.  Towards a theory of chronic pain.

Authors:  A Vania Apkarian; Marwan N Baliki; Paul Y Geha
Journal:  Prog Neurobiol       Date:  2008-10-05       Impact factor: 11.685

7.  Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.

Authors:  Eric H Chudler; Ying Lu
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

Review 8.  Evaluation of reward from pain relief.

Authors:  Edita Navratilova; Jennifer Yanhua Xie; Tamara King; Frank Porreca
Journal:  Ann N Y Acad Sci       Date:  2013-03-15       Impact factor: 5.691

Review 9.  A key role of the basal ganglia in pain and analgesia--insights gained through human functional imaging.

Authors:  David Borsook; Jaymin Upadhyay; Eric H Chudler; Lino Becerra
Journal:  Mol Pain       Date:  2010-05-13       Impact factor: 3.395

10.  Correlation between ventral striatal catecholamine content and nociceptive thresholds in neuropathic mice.

Authors:  Anna M W Taylor; Niall P Murphy; Christopher J Evans; Catherine M Cahill
Journal:  J Pain       Date:  2014-06-02       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.